# Epirus Biopharmaceuticals (Switzerland) GmbH in Liquidation

> Swiss commercial-register record from Swiss Graph (graph.swiss), sourced
> from the Swiss Official Gazette of Commerce (SHAB/SOGC).
> Canonical profile: https://graph.swiss/companies/epirus-biopharmaceuticals-switzerland-gmbh-in-liquidation/59988

## Registry facts

- UID: CHE-336.285.238
- Status: deleted
- Legal form: limited liability company
- Registered: 2013-07-02
- Address: c/o Condor Group AG Untermüli 6 6300 Zug
- Location: Zug, zg
- Industry (NOGA): 642100, Activities of holding companies
- Capital: CHF 20'000.00

## Purpose

Halten, Verwalten und Veräussern von Beteiligungen an Unternehmen aller Art im In- und Ausland sowie Forschung, Entwicklung und Registrierung von Produkten aller Art in pharmazeutischen, chemischen, medizinischen, biotechnischen und verwandten Bereichen sowie Erbringung sämtlicher damit im Zusammenhang stehenden Dienstleistungen; vollständige Zweckumschreibung gemäss Statuten

## Previous names

- Epirus Switzerland GmbH
- (Epirus Switzerland S.à.r.l.) (Epirus Switzerland S.a.g.l) (Epirus Switzerland Ltd liab. Co)
- Epirus Biopharmaceuticals (Switzerland) GmbH
- (Epirus Biopharmaceuticals (Switzerland) Sàrl) (Epirus Biopharmaceuticals (Switzerland) Sagl) (Epirus Biopharmaceuticals (Switzerland) LLC)

## Registered officers

- EB Sub, Inc. — LLC member
- Epirus Biopharmaceuticals, Inc — LLC member
- Amit Munshi — chairperson of the management board — joint signing authority (any two to sign)
- Deborah Abbonizio — member of the executive board — joint signing authority (any two to sign)
- Beat Werder — member of the executive board — joint signing authority (any two to sign)
- Tamas Sziraczki — member of the executive board — joint signing authority (any two to sign)
- Robert Ticktin — member of the executive board — joint signing authority (any two to sign)
- Simon David Bedson — member of the executive board — joint signing authority (any two to sign)
- Laura Wahlberg — manager — joint signing authority (any two to sign)
- Cheryl Lassen — manager — joint signing authority (any two to sign)
- Kim Seth — manager — joint signing authority (any two to sign)
- Michael Wyand — manager — joint signing authority (any two to sign)
- Nicholas Plumeridge — manager — joint signing authority (any two to sign)
- Thomas Shea — manager — joint signing authority (any two to sign)
- Jeffrey Kagy — manager — joint signing authority (any two to sign)
- David Maki — member of the executive board — joint signing authority (any two to sign)
- Boris Javelle — having right to sign — joint signing authority (any two to sign)
- Vincent Aurentz — member of the executive board — joint signing authority (any two to sign)
- Paul Chen — member of the executive board — joint signing authority (any two to sign)
- Charles Laranjeira — member of the executive board — joint signing authority (any two to sign)
- Benjamin Gubler — general manager — individual signing authority
- Lene Biner Jensen — member of the executive board — individual signing authority

---

Machine-readable variant of https://graph.swiss/companies/epirus-biopharmaceuticals-switzerland-gmbh-in-liquidation/59988: registry facts only; the HTML
profile adds the corporate network, publications and live enrichment.
Site overview for agents: https://graph.swiss/llms.txt